Mona Fiuzat | Scholars@Duke

Mona Fiuzat
Adjunct Associate Professor in the Department of Medicine

Current Appointments & Affiliations

Adjunct Associate Professor in the Department of Medicine, Medicine, Clinical Pharmacology, Medicine 2015

Contact Information

DUMC Box 3356, Durham, NC 27710
1530 Key Blvd, #124, Arlington, VA 22209
mona.fiuzat@duke.edu (919) 450-8220

Background
Education, Training, & Certifications
- Ph.D., Mercer University School of Medicine 1998
Previous Appointments & Affiliations
- Associate Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2013 - 2015
- Assistant Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2011 - 2013
Research
Selected Grants
- GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC) awarded by National Institutes of Health 2012 - 2017
- Palliative Care in Heart Failure (PAL-HF) awarded by National Institutes of Health 2011 - 2016
- Pharmacometabolomics Research Network awarded by National Institutes of Health 2010 - 2011
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Tsutsui, Hiroyuki, Nancy M. Albert, Andrew J. S. Coats, Stefan D. Anker, Antoni Bayes-Genis, Javed Butler, Ovidiu Chioncel, et al. “Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.” J Card Fail 29, no. 5 (May 2023): 787–804. https://doi.org/10.1016/j.cardfail.2023.02.009.
    Full Text Link to Item
  - Tsutsui, Hiroyuki, Nancy M. Albert, Andrew J. S. Coats, Stefan D. Anker, Antoni Bayes-Genis, Javed Butler, Ovidiu Chioncel, et al. “Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.” Eur J Heart Fail, April 26, 2023. https://doi.org/10.1002/ejhf.2848.
    Full Text Link to Item
  - Bhatt, Ankeet S., Matthew Dimond, Mona Fiuzat, Muthiah Vaduganathan, Orly Vardeny, Punag Divanji, Jan Komtebedde, et al. “Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory.” Jacc Heart Fail 11, no. 2 (February 2023): 254–57. https://doi.org/10.1016/j.jchf.2022.11.024.
    Full Text Link to Item
  - Harrington, Josephine, Andrew B. Nixon, Melissa A. Daubert, Eric Yow, James Januzzi, Mona Fiuzat, David J. Whellan, et al. “Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure.” J Card Fail, January 8, 2023. https://doi.org/10.1016/j.cardfail.2022.12.011.
    Full Text Link to Item
  - Khan, Muhammad Shahzeb, Aymen Ahmed, Stephen J. Greene, Mona Fiuzat, Michelle M. Kittleson, Javed Butler, George L. Bakris, and Gregg C. Fonarow. “Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review.” J Card Fail 29, no. 1 (January 2023): 87–107. https://doi.org/10.1016/j.cardfail.2022.09.013.
    Full Text Link to Item
  - Psotka, Mitchell A., William T. Abraham, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Tariq Ahmad, G Michael Felker, et al. “Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.” Jacc Heart Fail 10, no. 12 (December 2022): 889–901. https://doi.org/10.1016/j.jchf.2022.09.012.
    Full Text Link to Item
  - Lala, Anuradha, Christopher M. O’Connor, Mona Fiuzat, Mark H. Drazner, and Robert J. Mentz. “Recognizing Efforts that Support Clinical Trial Success: Site-Based Research Awards from the Heart Failure Collaboratory and Heart Failure Society of America.” J Card Fail 28, no. 9 (September 2022): 1387–89. https://doi.org/10.1016/j.cardfail.2022.08.001.
    Full Text Link to Item
  - Pierce, Jacob B., Robert J. Mentz, Jie-Lena Sun, Brooke Alhanti, David J. Whellan, William E. Kraus, Ileana L. Piña, Mona Fiuzat, Christopher M. O’Connor, and Stephen J. Greene. “Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial.” Am Heart J 251 (September 2022): 115–26. https://doi.org/10.1016/j.ahj.2022.05.018.
    Full Text Link to Item
  - Butt, Jawad H., Pooja Dewan, Ersilia M. DeFilippis, Tor Biering-Sørensen, Kieran F. Docherty, Pardeep S. Jhund, Mikhail N. Kosiborod, et al. “Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF.” Jacc. Heart Failure 10, no. 8 (August 2022): 543–55. https://doi.org/10.1016/j.jchf.2022.03.009.
    Full Text
  - DeFilippis, Ersilia M., Melvin Echols, Philip B. Adamson, Wayne B. Batchelor, Lauren B. Cooper, Lawton S. Cooper, Patrice Desvigne-Nickens, et al. “Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.” Jama Cardiol 7, no. 5 (May 1, 2022): 540–48. https://doi.org/10.1001/jamacardio.2022.0161.
    Full Text Link to Item
  - Tobin, Rachel S., Michael F. Cosiano, Christopher M. O’Connor, Mona Fiuzat, Bradi B. Granger, Joseph G. Rogers, James A. Tulsky, Karen E. Steinhauser, and Robert J. Mentz. “Spirituality in Patients With Heart Failure.” Jacc Heart Fail 10, no. 4 (April 2022): 217–26. https://doi.org/10.1016/j.jchf.2022.01.014.
    Full Text Link to Item
  - Fiuzat, Mona, Carine E. Hamo, Javed Butler, William T. Abraham, Ersilia M. DeFilippis, Gregg C. Fonarow, Joann Lindenfeld, et al. “Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.” J Am Coll Cardiol 79, no. 5 (February 8, 2022): 504–10. https://doi.org/10.1016/j.jacc.2021.11.033.
    Full Text Link to Item
  - Ezekowitz, Justin A., Wendimagegn Alemayehu, Sarah Rathwell, Andrew D. Grant, Mona Fiuzat, David J. Whellan, Tariq Ahmad, et al. “The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.” Esc Heart Fail 9, no. 1 (February 2022): 77–86. https://doi.org/10.1002/ehf2.13692.
    Full Text Link to Item
  - Granger, Bradi B., James A. Tulsky, Brystana G. Kaufman, Robert M. Clare, Kevin Anstrom, Daniel B. Mark, Kimberly A. Johnson, et al. “Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience.” J Card Fail 28, no. 2 (February 2022): 334–38. https://doi.org/10.1016/j.cardfail.2021.08.021.
    Full Text Link to Item
  - Tobin, Rachel S., Marc D. Samsky, Maragatha Kuchibhatla, Christopher M. O’Connor, Mona Fiuzat, Haider J. Warraich, Kevin J. Anstrom, et al. “Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial.” J Palliat Med 25, no. 2 (February 2022): 296–300. https://doi.org/10.1089/jpm.2021.0220.
    Full Text Link to Item
  - Ostrominski, John W., Sameer Hirji, Ankeet S. Bhatt, Javed Butler, Mona Fiuzat, Gregg C. Fonarow, Paul A. Heidenreich, et al. “Cost and Value in Contemporary Heart Failure Clinical Guidance Documents.” Jacc Heart Fail 10, no. 1 (January 2022): 1–11. https://doi.org/10.1016/j.jchf.2021.08.002.
    Full Text Link to Item
  - Pahuja, Mohit, Eric S. Leifer, John-Ross D. Clarke, Tariq Ahmad, Melissa A. Daubert, Daniel B. Mark, Lawton Cooper, et al. “Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study.” Prog Cardiovasc Dis 71 (2022): 79–85. https://doi.org/10.1016/j.pcad.2022.04.010.
    Full Text Link to Item
  - Chouairi, Fouad, Michael A. Fuery, Clancy W. Mullan, Cesar Caraballo, Sounok Sen, Christopher Maulion, Samuel T. Wilkinson, et al. “The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial.” Journal of Cardiac Failure 27, no. 12 (December 2021): 1359–66. https://doi.org/10.1016/j.cardfail.2021.06.008.
    Full Text
  - Thrasher, Claire, J Herbert Patterson, and Mona Fiuzat. “Universal Definition and Classification of Heart Failure: Pharmacists' Perspective: Optimizing Guideline-Directed Medical Therapy and Educating Stakeholders.” Journal of Cardiac Failure 27, no. 12 (December 2021): 1310–12. https://doi.org/10.1016/j.cardfail.2021.09.014.
    Full Text
  - Wan, Luxi, Marc D. Samsky, Christopher M. O’Connor, Amanda Stebbins, Brooke Alhanti, Haider J. Warraich, Kimberly S. Johnson, et al. “Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire With a Palliative Care Intervention for Patients With Advanced Heart Failure: Insights from PAL-HF.” J Card Fail 27, no. 12 (December 2021): 1476–78. https://doi.org/10.1016/j.cardfail.2021.02.007.
    Full Text Link to Item
  - Rao, Vishal N., Evan Murray, Javed Butler, Lauren B. Cooper, Zachary L. Cox, Mona Fiuzat, Jennifer B. Green, et al. “In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 78, no. 20 (November 16, 2021): 2004–12. https://doi.org/10.1016/j.jacc.2021.08.064.
    Full Text Link to Item
  - Anchouche, Khalil, Malik Elharram, Emily Oulousian, Amir Razaghizad, Robert Avram, Guillaume Marquis-Gravel, Varinder Kaur Randhawa, et al. “Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review.” Can J Cardiol 37, no. 9 (September 2021): 1438–49. https://doi.org/10.1016/j.cjca.2021.07.001.
    Full Text Link to Item
  - Fuery, Michael A., Fouad Chouairi, James L. Januzzi, Gordon W. Moe, Cesar Caraballo, Megan McCullough, P Elliott Miller, et al. “Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure.” Jacc Heart Fail 9, no. 7 (July 2021): 497–505. https://doi.org/10.1016/j.jchf.2021.02.011.
    Full Text Link to Item
  - Batchelor, Wayne B., Abdulla A. Damluji, Celina Yong, Mona Fiuzat, Scott D. Barnett, David E. Kandzari, Matthew W. Sherwood, et al. “Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.” Am Heart J 236 (June 2021): 37–48. https://doi.org/10.1016/j.ahj.2021.02.003.
    Full Text Link to Item
  - Kaufman, Brystana G., Bradi B. Granger, Jie-Lena Sun, Gillian Sanders, Donald H. Taylor, Daniel B. Mark, Haider Warraich, et al. “The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial.” J Card Fail 27, no. 6 (June 2021): 662–69. https://doi.org/10.1016/j.cardfail.2021.02.019.
    Full Text Link to Item
  - Daubert, Melissa A., Eric Yow, Huiman X. Barnhart, Ileana L. Piña, Tariq Ahmad, Eric Leifer, Lawton Cooper, et al. “Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction.” J Am Heart Assoc 10, no. 10 (May 18, 2021): e019712. https://doi.org/10.1161/JAHA.120.019712.
    Full Text Link to Item
  - Lindenfeld, JoAnn, Mona Fiuzat, and Christopher O’Connor. “Promoting Diversity in Clinical Trial Leadership: A Call to Action.” Jacc Heart Fail 9, no. 5 (May 2021): 401–2. https://doi.org/10.1016/j.jchf.2021.03.005.
    Full Text Link to Item
  - Bhatt, Ankeet S., Mona Fiuzat, JoAnn Lindenfeld, Christopher M. O’Connor, and Javed Butler. “Reply: Improving Heart Failure Therapeutics: Thinking Outside the Pillbox?” Jacc Heart Fail 9, no. 4 (April 2021): 320–21. https://doi.org/10.1016/j.jchf.2021.01.005.
    Full Text Link to Item
  - Bozkurt, Biykem, Andrew J. S. Coats, Hiroyuki Tsutsui, Ca Magdy Abdelhamid, Stamatis Adamopoulos, Nancy Albert, Stefan D. Anker, et al. “Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.” Eur J Heart Fail 23, no. 3 (March 2021): 352–80. https://doi.org/10.1002/ejhf.2115.
    Full Text Link to Item
  - Bozkurt, Biykem, Andrew Js Coats, Hiroyuki Tsutsui, Magdy Abdelhamid, Stamatis Adamopoulos, Nancy Albert, Stefan D. Anker, et al. “Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.” J Card Fail, March 1, 2021. https://doi.org/10.1016/j.cardfail.2021.01.022.
    Full Text Link to Item
  - Brooksbank, Jeremy A., Stephen J. Greene, Hailey M. Harris, Amanda Stebbins, Mona Fiuzat, David J. Whellan, Brooke Alhanti, et al. “Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial.” Am Heart J 233 (March 2021): 1–4. https://doi.org/10.1016/j.ahj.2020.11.003.
    Full Text Link to Item
  - DeFilippis, Ersilia M., and Mona Fiuzat. “Putting the "Optimal" in Optimal Medical Therapy.” Jacc Heart Fail 9, no. 1 (January 2021): 39–41. https://doi.org/10.1016/j.jchf.2020.08.016.
    Full Text Link to Item
  - Bhatt, Ankeet S., William T. Abraham, JoAnn Lindenfeld, Michael Bristow, Peter E. Carson, G Michael Felker, Gregg C. Fonarow, et al. “Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.” Jacc Heart Fail 9, no. 1 (January 2021): 1–12. https://doi.org/10.1016/j.jchf.2020.10.014.
    Full Text Link to Item
  - Abraham, William T., Mitchell A. Psotka, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Roxana Mehran, Amrut V. Ambardekar, et al. “Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.” Eur J Heart Fail 22, no. 12 (December 2020): 2175–86. https://doi.org/10.1002/ejhf.2018.
    Full Text Link to Item
  - Angraal, Suveen, César Caraballo, Peter Kahn, Ambika Bhatnagar, Bikramjot Singh, F Perry Wilson, Mona Fiuzat, et al. “Geographical affiliation with top 10 NIH-funded academic medical centers and differences between mortality from cardiovascular disease and cancer.” Am Heart J 230 (December 2020): 54–58. https://doi.org/10.1016/j.ahj.2020.08.014.
    Full Text Link to Item
  - Perego, Carlotta, Marco Sbolli, Claudia Specchia, Mona Fiuzat, Zachary R. McCaw, Marco Metra, Chiara Oriecuia, et al. “Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation.” Jacc Heart Fail 8, no. 12 (December 2020): 973–83. https://doi.org/10.1016/j.jchf.2020.07.005.
    Full Text Link to Item
  - Psotka, Mitchell A., William T. Abraham, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Tariq Ahmad, Ankeet S. Bhatt, et al. “Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel.” J Am Coll Cardiol 76, no. 20 (November 17, 2020): 2368–78. https://doi.org/10.1016/j.jacc.2020.09.544.
    Full Text Link to Item
  - Sbolli, Marco, Mona Fiuzat, Dario Cani, and Christopher M. O’Connor. “Depression and heart failure: the lonely comorbidity.” Eur J Heart Fail 22, no. 11 (November 2020): 2007–17. https://doi.org/10.1002/ejhf.1865.
    Full Text Link to Item
  - Psotka, Mitchell A., Mona Fiuzat, Marco Metra, and Christopher M. O’Connor. “Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.” J Am Coll Cardiol 76, no. 14 (October 6, 2020): 1717–18. https://doi.org/10.1016/j.jacc.2020.08.013.
    Full Text Link to Item
  - Psotka, Mitchell A., Mona Fiuzat, Scott D. Solomon, Cynthia Chauhan, G Michael Felker, Javed Butler, John R. Teerlink, Shashank S. Sinha, Christopher M. O’Connor, and Marvin A. Konstam. “Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology.” Circulation 142, no. 8 (August 25, 2020): 790–98. https://doi.org/10.1161/CIRCULATIONAHA.119.044976.
    Full Text Link to Item
  - Abraham, William T., Mona Fiuzat, Mitchell A. Psotka, and Christopher M. O’Connor. “Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19.” Jacc Heart Fail 8, no. 8 (August 2020): 692–94. https://doi.org/10.1016/j.jchf.2020.06.006.
    Full Text Link to Item
  - Reza, Nosheen, Ayman Samman Tahhan, Nadim Mahmud, Ersilia M. DeFilippis, Alaaeddin Alrohaibani, Muthiah Vaduganathan, Stephen J. Greene, et al. “Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials.” Circ Heart Fail 13, no. 8 (August 2020): e006605. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006605.
    Full Text Link to Item
  - Fiuzat, Mona, Justin Ezekowitz, Wendimagegn Alemayehu, Cynthia M. Westerhout, Marco Sbolli, Dario Cani, David J. Whellan, et al. “Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiol 5, no. 7 (July 1, 2020): 757–64. https://doi.org/10.1001/jamacardio.2020.0640.
    Full Text Link to Item
  - Psotka, Mitchell A., Federica Latta, Dario Cani, Mona Fiuzat, Marco Sbolli, Scott Barnett, Marco Metra, and Christopher M. O’Connor. “Publication Rates of Heart Failure Clinical Trials Remain Low.” J Am Coll Cardiol 75, no. 25 (June 30, 2020): 3151–61. https://doi.org/10.1016/j.jacc.2020.04.068.
    Full Text Link to Item
  - Fiuzat, Mona, Naomi Lowy, Norman Stockbridge, Marco Sbolli, Federica Latta, JoAnn Lindenfeld, Eldrin F. Lewis, et al. “Endpoints in Heart Failure Drug Development: History and Future.” Jacc Heart Fail 8, no. 6 (June 2020): 429–40. https://doi.org/10.1016/j.jchf.2019.12.011.
    Full Text Link to Item
  - Abraham, William T., Mona Fiuzat, Mitchell A. Psotka, and Christopher M. O’Connor. “Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.” Jacc Heart Fail 8, no. 5 (May 2020): 423–25. https://doi.org/10.1016/j.jchf.2020.03.005.
    Full Text Link to Item
  - Ibrahim, Nasrien E., John C. Burnett, Javed Butler, Alexander Camacho, G Michael Felker, Mona Fiuzat, Christopher O’Connor, et al. “Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper.” Jacc Heart Fail 8, no. 5 (May 2020): 347–58. https://doi.org/10.1016/j.jchf.2019.12.010.
    Full Text Link to Item
  - Truby, Lauren K., Christopher O’Connor, Mona Fiuzat, Amanda Stebbins, Adrian Coles, Chetan B. Patel, Bradi Granger, et al. “Sex Differences in Quality of Life and Clinical Outcomes in Patients With Advanced Heart Failure: Insights From the PAL-HF Trial.” Circ Heart Fail 13, no. 4 (April 2020): e006134. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006134.
    Full Text Link to Item
  - Psotka, Mitchell A., Gregg C. Fonarow, Larry A. Allen, Karen E. Joynt Maddox, Mona Fiuzat, Paul Heidenreich, Adrian F. Hernandez, Marvin A. Konstam, Clyde W. Yancy, and Christopher M. O’Connor. “The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper.” Jacc Heart Fail 8, no. 1 (January 2020): 1–11. https://doi.org/10.1016/j.jchf.2019.07.012.
    Full Text Link to Item
  - Butler, Javed, Milton Packer, Stephen J. Greene, Mona Fiuzat, Stefan D. Anker, Kevin J. Anstrom, Peter E. Carson, et al. “Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.” Circulation 140, no. 25 (December 17, 2019): 2108–18. https://doi.org/10.1161/CIRCULATIONAHA.119.042155.
    Full Text Link to Item
  - Caraballo, César, Nihar R. Desai, Hillary Mulder, Brooke Alhanti, F Perry Wilson, Mona Fiuzat, G Michael Felker, et al. “Clinical Implications of the New York Heart Association Classification.” J Am Heart Assoc 8, no. 23 (December 3, 2019): e014240. https://doi.org/10.1161/JAHA.119.014240.
    Full Text Link to Item
  - Psotka, Mitchell A., Mona Fiuzat, Peter E. Carson, David P. Kao, Jeffrey Cerkvenik, Daniel E. Schaber, Patrick Verta, et al. “Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.” Jacc Heart Fail 7, no. 11 (November 2019): 913–21. https://doi.org/10.1016/j.jchf.2019.07.001.
    Full Text Link to Item
  - Januzzi, James L., Tariq Ahmad, Hillary Mulder, Adrian Coles, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, et al. “Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 74, no. 9 (September 3, 2019): 1205–17. https://doi.org/10.1016/j.jacc.2019.06.055.
    Full Text Link to Item
  - Ambrosy, Andrew P., Robert J. Mentz, Mona Fiuzat, John G. F. Cleland, Stephen J. Greene, Christopher M. O’Connor, John R. Teerlink, Faiez Zannad, and Scott D. Solomon. “Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].” Eur J Heart Fail 21, no. 6 (June 2019): 819. https://doi.org/10.1002/ejhf.1480.
    Full Text Link to Item
  - O’Connor, Christopher, Mona Fiuzat, Hillary Mulder, Adrian Coles, Tariq Ahmad, Justin A. Ezekowitz, Kirkwood F. Adams, et al. “Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.” Eur J Heart Fail 21, no. 6 (June 2019): 770–78. https://doi.org/10.1002/ejhf.1450.
    Full Text Link to Item
  - Psotka, Mitchell A., Susan E. Ammon, Mona Fiuzat, Biykem Bozkurt, Eugene S. Chung, Robert T. Cole, Stephen J. Greene, et al. “Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.” Jacc Heart Fail 7, no. 5 (May 2019): 431–38. https://doi.org/10.1016/j.jchf.2019.02.008.
    Full Text Link to Item
  - Vaduganathan, Muthiah, Ayman Samman Tahhan, Alaaeddin Alrohaibani, Stephen J. Greene, Gregg C. Fonarow, Orly Vardeny, JoAnn Lindenfeld, et al. “Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?” Jacc Heart Fail 7, no. 3 (March 2019): 267–71. https://doi.org/10.1016/j.jchf.2018.12.016.
    Full Text Link to Item
  - Daubert, Melissa A., Kirkwood Adams, Eric Yow, Huiman X. Barnhart, Pamela S. Douglas, Susan Rimmer, Casey Norris, et al. “NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.” Jacc Heart Fail 7, no. 2 (February 2019): 158–68. https://doi.org/10.1016/j.jchf.2018.10.014.
    Full Text Link to Item
  - Piccini, Jonathan P., Sean D. Pokorney, Kevin J. Anstrom, Olaf Oldenburg, Naresh M. Punjabi, Mona Fiuzat, Gudaye Tasissa, et al. “Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea.” Heart Rhythm 16, no. 1 (January 2019): 91–97. https://doi.org/10.1016/j.hrthm.2018.07.027.
    Full Text Link to Item
  - Mark, Daniel B., Patricia A. Cowper, Kevin J. Anstrom, Shubin Sheng, Melanie R. Daniels, J David Knight, Khaula N. Baloch, et al. “Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.” J Am Coll Cardiol 72, no. 21 (November 27, 2018): 2551–62. https://doi.org/10.1016/j.jacc.2018.08.2184.
    Full Text Link to Item
  - Fudim, Marat, Rahul Loungani, Shannon M. Doerfler, Adrian Coles, Stephen J. Greene, Lauren B. Cooper, Mona Fiuzat, Christopher M. O’Connor, Joseph G. Rogers, and Robert J. Mentz. “Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.” Am Heart J 204 (October 2018): 163–73. https://doi.org/10.1016/j.ahj.2018.07.019.
    Full Text Link to Item
  - Sharma, Abhinav, Lauren B. Cooper, Mona Fiuzat, Robert J. Mentz, João Pedro Ferreira, Javed Butler, David Fitchett, Alan Charles Moses, Christopher O’Connor, and Faiez Zannad. “Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus.” Jacc Heart Fail 6, no. 10 (October 2018): 813–22. https://doi.org/10.1016/j.jchf.2018.05.020.
    Full Text Link to Item
  - Tahhan, Ayman Samman, Muthiah Vaduganathan, Stephen J. Greene, Gregg C. Fonarow, Mona Fiuzat, Mariell Jessup, JoAnn Lindenfeld, Christopher M. O’Connor, and Javed Butler. “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review.” Jama Cardiol 3, no. 10 (October 1, 2018): 1011–19. https://doi.org/10.1001/jamacardio.2018.2559.
    Full Text Link to Item
  - Greene, Stephen J., Robert J. Mentz, Mona Fiuzat, Javed Butler, Scott D. Solomon, Andrew P. Ambrosy, Cyrus Mehta, John R. Teerlink, Faiez Zannad, and Christopher M. O’Connor. “Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.” Circulation 138, no. 10 (September 4, 2018): 1039–53. https://doi.org/10.1161/CIRCULATIONAHA.118.034668.
    Full Text Link to Item
  - Parikh, Kishan S., Kavita Sharma, Mona Fiuzat, Howard K. Surks, Jyothis T. George, Narimon Honarpour, Christopher Depre, et al. “Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials.” Jacc Heart Fail 6, no. 8 (August 2018): 619–32. https://doi.org/10.1016/j.jchf.2018.06.008.
    Full Text Open Access Copy Link to Item
  - Parikh, Kishan S., Mona Fiuzat, Gordon Davis, Megan Neely, Penny Blain-Nelson, David J. Whellan, William T. Abraham, et al. “Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.” Circ Genom Precis Med 11, no. 8 (August 2018): e002210. https://doi.org/10.1161/CIRCGEN.117.002210.
    Full Text Link to Item
  - Daubert, Melissa A., David J. Whellan, Holger Woehrle, Gudaye Tasissa, Kevin J. Anstrom, JoAnn Lindenfeld, Adam Benjafield, et al. “Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial.” Am Heart J 201 (July 2018): 40–48. https://doi.org/10.1016/j.ahj.2018.03.026.
    Full Text Link to Item
  - Ambrosy, Andrew P., Robert J. Mentz, Mona Fiuzat, John G. F. Cleland, Stephen J. Greene, Christopher M. O’Connor, John R. Teerlink, Faiez Zannad, and Scott D. Solomon. “The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.” Eur J Heart Fail 20, no. 6 (June 2018): 963–72. https://doi.org/10.1002/ejhf.1159.
    Full Text Link to Item
  - O’Connor, Christopher M., Mitchell A. Psotka, Mona Fiuzat, JoAnn Lindenfeld, William T. Abraham, Michael R. Bristow, Daniel Canos, et al. “Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.” J Am Coll Cardiol 71, no. 4 (January 30, 2018): 443–53. https://doi.org/10.1016/j.jacc.2017.11.048.
    Full Text Link to Item
  - Sharma, Abhinav, Susanna R. Stevens, Joseph Lucas, Mona Fiuzat, Kirkwood F. Adams, David J. Whellan, Mark P. Donahue, et al. “Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.” Jacc Heart Fail 5, no. 10 (October 2017): 724–34. https://doi.org/10.1016/j.jchf.2017.07.013.
    Full Text Link to Item
  - Felker, G Michael, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L. Januzzi, et al. “Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” Jama 318, no. 8 (August 22, 2017): 713–20. https://doi.org/10.1001/jama.2017.10565.
    Full Text Link to Item
  - Rogers, Joseph G., Chetan B. Patel, Robert J. Mentz, Bradi B. Granger, Karen E. Steinhauser, Mona Fiuzat, Patricia A. Adams, et al. “Palliative Care in Heart Failure The PAL-HF Randomized, Controlled Clinical Trial.” Journal of the American College of Cardiology 70, no. 3 (July 18, 2017): 332–41.
    Link to Item
  - Rogers, Joseph G., Chetan B. Patel, Robert J. Mentz, Bradi B. Granger, Karen E. Steinhauser, Mona Fiuzat, Patricia A. Adams, et al. “Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.” J Am Coll Cardiol 70, no. 3 (July 18, 2017): 331–41. https://doi.org/10.1016/j.jacc.2017.05.030.
    Full Text Link to Item
  - Banks, Adam, Samuel Broderick, Karen Chiswell, Linda Shaw, Adam Devore, Mona Fiuzat, Christopher O’Connor, Gary Michael Felker, Eric Velazquez, and Robert Mentz. “Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease).” Am J Cardiol 119, no. 11 (June 1, 2017): 1703–9. https://doi.org/10.1016/j.amjcard.2017.02.053.
    Full Text Link to Item
  - O’Connor, C. M., D. J. Whellan, M. Fiuzat, N. M. Punjabi, G. Tasissa, K. J. Anstrom, A. Benjafield, et al. “Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial (vol 69, pg 1577, 2017).” Journal of the American College of Cardiology 69, no. 18 (May 9, 2017): 2355–2355.
    Link to Item
  - Luo, Nancy, Peter Merrill, Kishan S. Parikh, David J. Whellan, Ileana L. Piña, Mona Fiuzat, William E. Kraus, et al. “Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.” J Am Coll Cardiol 69, no. 13 (April 4, 2017): 1683–91. https://doi.org/10.1016/j.jacc.2017.01.032.
    Full Text Link to Item
  - O’Connor, Christopher M., David J. Whellan, Mona Fiuzat, Naresh M. Punjabi, Gudaye Tasissa, Kevin J. Anstrom, Adam V. Benjafield, et al. “Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.” J Am Coll Cardiol 69, no. 12 (March 28, 2017): 1577–87. https://doi.org/10.1016/j.jacc.2017.01.041.
    Full Text Link to Item
  - Felker, G Michael, Robert J. Mentz, Robert T. Cole, Kirkwood F. Adams, Gregory F. Egnaczyk, Mona Fiuzat, Chetan B. Patel, et al. “Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.” J Am Coll Cardiol 69, no. 11 (March 21, 2017): 1399–1406. https://doi.org/10.1016/j.jacc.2016.09.004.
    Full Text Link to Item
  - Fiuzat, Mona, Susan T. Mayne, Matt Hillebrenner, Norman Stockbridge, Bram Zuckerman, and Robert M. Califf. “JACC: Heart Failure Series: FDA in the 21st Century: Focus on Nutrition and Heart Failure Prevention.” Jacc Heart Fail 5, no. 3 (March 2017): 229–31. https://doi.org/10.1016/j.jchf.2016.12.012.
    Full Text Link to Item
  - Fiuzat, Mona, Tamar S. Nordenberg, Mitchell Zeller, Matthew G. Hillebrenner, Norman Stockbridge, Bram Zuckerman, and Robert M. Califf. “FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention.” Jacc Heart Fail 5, no. 2 (February 2017): 152–53. https://doi.org/10.1016/j.jchf.2016.11.010.
    Full Text Link to Item
  - Ferdinand, Keith C., Fortunato Fred Senatore, Helene Clayton-Jeter, Dennis R. Cryer, John C. Lewin, Samar A. Nasser, Mona Fiuzat, and Robert M. Califf. “Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.” J Am Coll Cardiol 69, no. 4 (January 31, 2017): 437–51. https://doi.org/10.1016/j.jacc.2016.11.034.
    Full Text Link to Item
  - Stockbridge, Norman, Kristen Miller, Shashi Amur, Matthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, and Robert M. Califf. “The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.” Jacc Heart Fail 5, no. 1 (January 2017): 67–70. https://doi.org/10.1016/j.jchf.2016.10.009.
    Full Text Link to Item
  - Hillebrenner, Matthew, Bram Zuckerman, Mona Fiuzat, Norman Stockbridge, and Robert Califf. “The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.” Jacc Heart Fail 4, no. 12 (December 2016): 974–77. https://doi.org/10.1016/j.jchf.2016.09.007.
    Full Text Link to Item
  - Fiuzat, Mona, and Robert M. Califf. “The US Food and Drug Administration and the Future of Cardiovascular Medicine.” Jama Cardiol 1, no. 8 (November 1, 2016): 950–52. https://doi.org/10.1001/jamacardio.2016.2580.
    Full Text Link to Item
  - Rogers, J. G., C. B. Patel, R. J. Mentz, K. E. Steinhauser, B. B. Granger, M. Fiuzat, P. A. Adams, et al. “Palliative Care in Heart Failure: Results of a Randomized, Controlled Clinical Trial.” Journal of Cardiac Failure 22, no. 11 (November 2016): 940–940. https://doi.org/10.1016/j.cardfail.2016.09.014.
    Full Text
  - Parikh, Kishan S., Adrian Coles, Phillip J. Schulte, William E. Kraus, Jerome L. Fleg, Steven J. Keteyian, Ileana L. Piña, et al. “Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION).” Am J Cardiol 118, no. 8 (October 15, 2016): 1211–16. https://doi.org/10.1016/j.amjcard.2016.07.040.
    Full Text Link to Item
  - Fiuzat, Mona, Norman Stockbridge, and Robert M. Califf. “Resourcing Drug Development Commensurate With its Public Health Importance: The Road Ahead.” Jacc Basic Transl Sci 1, no. 5 (August 2016): 309–12. https://doi.org/10.1016/j.jacbts.2016.07.003.
    Full Text Link to Item
  - Kelly, Jacob P., Allison Dunning, Phillip J. Schulte, Mona Fiuzat, Eric S. Leifer, Jerome L. Fleg, Lawton S. Cooper, et al. “Statins and Exercise Training Response in Heart Failure Patients: Insights From HF-ACTION.” Jacc Heart Fail 4, no. 8 (August 2016): 617–24. https://doi.org/10.1016/j.jchf.2016.05.006.
    Full Text Link to Item
  - Banks, Adam Z., Robert J. Mentz, Amanda Stebbins, Catherine R. Mikus, Phillip J. Schulte, Jerome L. Fleg, Lawton S. Cooper, et al. “Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial.” J Card Fail 22, no. 7 (July 2016): 485–91. https://doi.org/10.1016/j.cardfail.2015.12.007.
    Full Text Link to Item
  - Biegus, Jan, Hans L. Hillege, Douwe Postmus, Mattia A. E. Valente, Daniel M. Bloomfield, John G. F. Cleland, Gad Cotter, et al. “Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.” Eur J Heart Fail 18, no. 7 (July 2016): 830–39. https://doi.org/10.1002/ejhf.532.
    Full Text Link to Item
  - O’Connor, Christopher M., Mona Fiuzat, and JoAnn Lindenfeld. “Are We Really in Love With Old Therapies?” Jacc Heart Fail, April 12, 2016. https://doi.org/10.1016/j.jchf.2016.02.011.
    Full Text Link to Item
  - Garber, Adam M., Robert J. Mentz, Hussein R. Al-Khalidi, Linda K. Shaw, Mona Fiuzat, Christopher M. O’Connor, and Eric J. Velazquez. “Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction.” J Thromb Thrombolysis 41, no. 3 (April 2016): 365–73. https://doi.org/10.1007/s11239-015-1252-0.
    Full Text Link to Item
  - Fiuzat, Mona, Olaf Oldenberg, David J. Whellan, Holger Woehrle, Naresh M. Punjabi, Kevin J. Anstrom, Amy B. Blase, Adam V. Benjafield, JoAnn Lindenfeld, and Christopher M. O’Connor. “Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study.” Contemp Clin Trials 47 (March 2016): 158–64. https://doi.org/10.1016/j.cct.2016.01.001.
    Full Text Link to Item
  - Fiuzat, Mona, Daniel Wojdyla, Ileana Pina, Kirkwood Adams, David Whellan, and Christopher M. O’Connor. “Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.” Jacc Heart Fail 4, no. 2 (February 2016): 109–15. https://doi.org/10.1016/j.jchf.2015.09.002.
    Full Text Link to Item
  - Ahmad, Tariq, Jacob P. Kelly, Robert W. McGarrah, Anne S. Hellkamp, Mona Fiuzat, Jeffrey M. Testani, Teresa S. Wang, et al. “Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.” J Am Coll Cardiol 67, no. 3 (January 26, 2016): 291–99. https://doi.org/10.1016/j.jacc.2015.10.079.
    Full Text Link to Item
  - Ahmad, Tariq, Nihar Desai, Francis Wilson, Phillip Schulte, Allison Dunning, Daniel Jacoby, Larry Allen, et al. “Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles.” Plos One 11, no. 2 (2016): e0145881. https://doi.org/10.1371/journal.pone.0145881.
    Full Text Link to Item
  - Felker, G Michael, Robert J. Mentz, Kirkwood F. Adams, Robert T. Cole, Gregory F. Egnaczyk, Chetan B. Patel, Mona Fiuzat, et al. “Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials.” Circ Heart Fail 8, no. 5 (September 2015): 997–1005. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002259.
    Full Text Link to Item
  - Mentz, Robert J., Eric J. Velazquez, Marco Metra, Colleen McKendry, Karen Chiswell, Mona Fiuzat, Michael M. Givertz, Adriaan A. Voors, John R. Teerlink, and Christopher M. O’Connor. “Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.” Future Cardiol 11, no. 5 (September 2015): 585–95. https://doi.org/10.2217/fca.15.56.
    Full Text Link to Item
  - Ahmad, Tariq, Emily C. O’Brien, Phillip J. Schulte, Susanna R. Stevens, Mona Fiuzat, Dalane W. Kitzman, Kirkwood F. Adams, et al. “Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure.” Circ Heart Fail 8, no. 4 (July 2015): 709–16. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001996.
    Full Text Link to Item
  - Harinstein, Matthew E., Javed Butler, Stephen J. Greene, Gregg C. Fonarow, Norman L. Stockbridge, Christopher M. O’Connor, Marc A. Pfeffer, et al. “Site selection for heart failure clinical trials in the USA.” Heart Fail Rev 20, no. 4 (July 2015): 375–83. https://doi.org/10.1007/s10741-015-9473-z.
    Full Text Link to Item
  - Mentz, Robert J., Marco Metra, Gad Cotter, Olga Milo, Colleen McKendry, Karen Chiswell, Beth A. Davison, et al. “Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.” Eur J Heart Fail 17, no. 7 (July 2015): 697–706. https://doi.org/10.1002/ejhf.308.
    Full Text Link to Item
  - Mentz, Robert J., Jonathan Buggey, Mona Fiuzat, Mads K. Ersbøll, Phillip J. Schulte, Adam D. DeVore, Eric L. Eisenstein, Kevin J. Anstrom, Christopher M. OʼConnor, and Eric J. Velazquez. “Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.” J Cardiovasc Pharmacol 65, no. 5 (May 2015): 438–43. https://doi.org/10.1097/FJC.0000000000000212.
    Full Text Open Access Copy Link to Item
  - Kelly, Jacob P., Robert J. Mentz, Alexandre Mebazaa, Adriaan A. Voors, Javed Butler, Lothar Roessig, Mona Fiuzat, et al. “Patient selection in heart failure with preserved ejection fraction clinical trials.” J Am Coll Cardiol 65, no. 16 (April 28, 2015): 1668–82. https://doi.org/10.1016/j.jacc.2015.03.043.
    Full Text Link to Item
  - Gandhi, Parul U., Shweta R. Motiwala, Arianna M. Belcher, Hanna K. Gaggin, Rory B. Weiner, Aaron L. Baggish, Mona Fiuzat, Hans-Peter Brunner-La Rocca, and James L. Januzzi. “Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.” Am Heart J 169, no. 3 (March 2015): 404-411.e3. https://doi.org/10.1016/j.ahj.2014.12.012.
    Full Text Link to Item
  - Butler, Javed, Gregg C. Fonarow, Christopher O’Connor, Kirkwood Adams, Robert O. Bonow, Robert J. Cody, Sean P. Collins, et al. “Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators.” Am Heart J 169, no. 3 (March 2015): 305–14. https://doi.org/10.1016/j.ahj.2014.12.001.
    Full Text Link to Item
  - Fiuzat, Mona, and John C. Burnett. “Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.” Jacc Heart Fail 3, no. 1 (January 2015): 68–69. https://doi.org/10.1016/j.jchf.2014.10.003.
    Full Text Link to Item
  - Mentz, Robert J., Mona Fiuzat, Linda K. Shaw, Afshin Farzaneh-Far, Christopher M O’Connor, and Salvador Borges-Neto. “Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction.” Open Heart 2, no. 1 (2015): e000284. https://doi.org/10.1136/openhrt-2015-000284.
    Full Text Open Access Copy Link to Item
  - Metra, Marco, Robert J. Mentz, Karen Chiswell, Daniel M. Bloomfield, John G. F. Cleland, Gad Cotter, Beth A. Davison, et al. “Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.” Eur J Heart Fail 17, no. 1 (January 2015): 109–18. https://doi.org/10.1002/ejhf.207.
    Full Text Link to Item
  - Mentz, Robert J., Jacob P. Kelly, Thomas G. von Lueder, Adriaan A. Voors, Carolyn S. P. Lam, Martin R. Cowie, Keld Kjeldsen, et al. “Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.” J Am Coll Cardiol 64, no. 21 (December 2, 2014): 2281–93. https://doi.org/10.1016/j.jacc.2014.08.036.
    Full Text Link to Item
  - Taylor, Mathew R., Albert Y. Sun, Gordon Davis, Mona Fiuzat, Stephen B. Liggett, and Michael R. Bristow. “Race, common genetic variation, and therapeutic response disparities in heart failure.” Jacc Heart Fail 2, no. 6 (December 2014): 561–72. https://doi.org/10.1016/j.jchf.2014.06.010.
    Full Text Link to Item
  - Mentz, Robert J., James A. Tulsky, Bradi B. Granger, Kevin J. Anstrom, Patricia A. Adams, Gwen C. Dodson, Mona Fiuzat, et al. “The palliative care in heart failure trial: rationale and design.” Am Heart J 168, no. 5 (November 2014): 645-651.e1. https://doi.org/10.1016/j.ahj.2014.07.018.
    Full Text Link to Item
  - Felker, G Michael, Tariq Ahmad, Kevin J. Anstrom, Kirkwood F. Adams, Lawton S. Cooper, Justin A. Ezekowitz, Mona Fiuzat, et al. “Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.” Jacc Heart Fail 2, no. 5 (October 2014): 457–65. https://doi.org/10.1016/j.jchf.2014.05.007.
    Full Text Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Michael J. Pencina, Nancy L. Geller, Faiez Zannad, John G. F. Cleland, James V. Snider, et al. “Charting a roadmap for heart failure biomarker studies.” Jacc Heart Fail 2, no. 5 (October 2014): 477–88. https://doi.org/10.1016/j.jchf.2014.02.005.
    Full Text Link to Item
  - Parikh, Kishan S., Tariq Ahmad, and Mona Fiuzat. “Potential applications of pharmacogenomics to heart failure therapies.” Heart Fail Clin 10, no. 4 (October 2014): 599–606. https://doi.org/10.1016/j.hfc.2014.07.007.
    Full Text Link to Item
  - Mentz, Robert J., Samuel Broderick, Linda K. Shaw, Karen Chiswell, Mona Fiuzat, and Christopher M. O’Connor. “Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events.” Eur J Heart Fail 16, no. 8 (August 2014): 854–60. https://doi.org/10.1002/ejhf.130.
    Full Text Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Benjamin Neely, Megan L. Neely, Michael J. Pencina, William E. Kraus, Faiez Zannad, et al. “Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.” Jacc Heart Fail 2, no. 3 (June 2014): 260–68. https://doi.org/10.1016/j.jchf.2013.12.004.
    Full Text Link to Item
  - Mentz, Robert J., Gad Cotter, John G. F. Cleland, Susanna R. Stevens, Karen Chiswell, Beth A. Davison, John R. Teerlink, et al. “International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial.” Eur J Heart Fail 16, no. 6 (June 2014): 614–24. https://doi.org/10.1002/ejhf.92.
    Full Text Link to Item
  - Mentz, Robert J., Keld Kjeldsen, Gian Paolo Rossi, Adriaan A. Voors, John G. F. Cleland, Stefan D. Anker, Mihai Gheorghiade, et al. “Decongestion in acute heart failure.” Eur J Heart Fail 16, no. 5 (May 2014): 471–82. https://doi.org/10.1002/ejhf.74.
    Full Text Link to Item
  - Mentz, Robert J., and Mona Fiuzat. “Sleep-disordered breathing in patients with heart failure.” Heart Fail Clin 10, no. 2 (April 2014): 243–50. https://doi.org/10.1016/j.hfc.2013.10.001.
    Full Text Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Daniel B. Mark, Ben Neely, Megan Neely, William E. Kraus, Dalane W. Kitzman, et al. “The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.” Am Heart J 167, no. 2 (February 2014): 193-202.e1. https://doi.org/10.1016/j.ahj.2013.10.018.
    Full Text Link to Item
  - Mentz, Robert J., Samuel Broderick, Linda K. Shaw, Mona Fiuzat, and Christopher M. O’Connor. “Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).” J Am Coll Cardiol 63, no. 3 (January 28, 2014): 251–58. https://doi.org/10.1016/j.jacc.2013.09.039.
    Full Text Link to Item
  - Dobre, Daniela, Jeffrey S. Borer, Kim Fox, Karl Swedberg, Kirkwood F. Adams, John G. F. Cleland, Alain Cohen-Solal, et al. “Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.” Eur J Heart Fail 16, no. 1 (January 2014): 76–85. https://doi.org/10.1093/eurjhf/hft129.
    Full Text Link to Item
  - Cleland, John G., Karen Chiswell, John R. Teerlink, Susanna Stevens, Mona Fiuzat, Michael M. Givertz, Beth A. Davison, et al. “Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.” Circ Heart Fail 7, no. 1 (January 2014): 76–87. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000284.
    Full Text Link to Item
  - Fiuzat, Mona, Phillip J. Schulte, Michael Felker, Tariq Ahmad, Megan Neely, Kirkwood F. Adams, Mark P. Donahue, et al. “Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.” J Card Fail 20, no. 1 (January 2014): 38–44. https://doi.org/10.1016/j.cardfail.2013.11.011.
    Full Text Link to Item
  - Meyer, Sven, Peter van der Meer, Barry M. Massie, Christopher M. O’Connor, Marco Metra, Piotr Ponikowski, John R. Teerlink, et al. “Sex-specific acute heart failure phenotypes and outcomes from PROTECT.” Eur J Heart Fail 15, no. 12 (December 2013): 1374–81. https://doi.org/10.1093/eurjhf/hft115.
    Full Text Link to Item
  - Felker, G Michael, Mona Fiuzat, Vivian Thompson, Linda K. Shaw, Megan L. Neely, Kirkwood F. Adams, David J. Whellan, et al. “Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.” Circ Heart Fail 6, no. 6 (November 2013): 1172–79. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000207.
    Full Text Link to Item
  - Mentz, Robert J., Gary Michael Felker, Tariq Ahmad, William Frank Peacock, Bertram Pitt, Mona Fiuzat, Aldo P. Maggioni, et al. “Learning from recent trials and shaping the future of acute heart failure trials.” Am Heart J 166, no. 4 (October 2013): 629–35. https://doi.org/10.1016/j.ahj.2013.08.001.
    Full Text Link to Item
  - Mentz, Robert J., George L. Bakris, Bernard Waeber, John J. V. McMurray, Mihai Gheorghiade, Luis M. Ruilope, Aldo P. Maggioni, et al. “The past, present and future of renin-angiotensin aldosterone system inhibition.” Int J Cardiol 167, no. 5 (September 1, 2013): 1677–87. https://doi.org/10.1016/j.ijcard.2012.10.007.
    Full Text Link to Item
  - Fiuzat, Mona, Christopher M. O’Connor, Francois Gueyffier, Alice M. Mascette, Nancy L. Geller, Alexandre Mebazaa, Adriaan A. Voors, et al. “Biomarker-guided therapies in heart failure: a forum for unified strategies.” J Card Fail 19, no. 8 (August 2013): 592–99. https://doi.org/10.1016/j.cardfail.2013.05.012.
    Full Text Link to Item
  - Aleong, Ryan G., William H. Sauer, Gordon Davis, Guinevere A. Murphy, J David Port, Inder S. Anand, Mona Fiuzat, et al. “Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.” Jacc Heart Fail 1, no. 4 (August 2013): 338–44. https://doi.org/10.1016/j.jchf.2013.04.002.
    Full Text Link to Item
  - Lazzarini, Valentina, Robert J. Mentz, Mona Fiuzat, Marco Metra, and Christopher M. O’Connor. “Heart failure in elderly patients: distinctive features and unresolved issues.” Eur J Heart Fail 15, no. 7 (July 2013): 717–23. https://doi.org/10.1093/eurjhf/hft028.
    Full Text Link to Item
  - Mentz, Robert J., Valentina Lazzarini, Mona Fiuzat, Marco Metra, Christopher M. O’Connor, and G Michael Felker. “Is there a rationale for antiplatelet therapy in acute heart failure?” Circ Heart Fail 6, no. 4 (July 2013): 869–76. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000381.
    Full Text Link to Item
  - Fiuzat, M., G. M. Felker, P. Shulte, M. Neely, K. Adams, M. Donahue, W. Kraus, I. Pina, D. Whellan, and C. M. O’connor. “Relationship between Galectin-3 Levels and Aldosterone Antagonist Use in Heart Failure: Analysis from the HF-ACTION Study.” European Journal of Heart Failure 12 (May 1, 2013): S273–S273.
    Link to Item
  - Kao, David P., Gordon Davis, Ryan Aleong, Christopher M. O’Connor, Mona Fiuzat, Peter E. Carson, Inder S. Anand, et al. “Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.” Eur J Heart Fail 15, no. 3 (March 2013): 324–33. https://doi.org/10.1093/eurjhf/hfs181.
    Full Text Link to Item
  - Fiuzat, Mona, Megan L. Neely, Aijing Z. Starr, William E. Kraus, G Michael Felker, Mark Donahue, Kirkwood Adams, Ileana L. Piña, David Whellan, and Christopher M. O’Connor. “Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy.” Eur J Heart Fail 15, no. 3 (March 2013): 258–66. https://doi.org/10.1093/eurjhf/hfs175.
    Full Text Link to Item
  - Mentz, Robert J., Daniel Wojdyla, Mona Fiuzat, Karen Chiswell, Gregg C. Fonarow, and Christopher M. O’Connor. “Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).” Am J Cardiol 111, no. 4 (February 15, 2013): 582–87. https://doi.org/10.1016/j.amjcard.2012.10.041.
    Full Text Link to Item
  - Mentz, Robert J., Phillip J. Schulte, Jerome L. Fleg, Mona Fiuzat, William E. Kraus, Ileana L. Piña, Steven J. Keteyian, et al. “Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).” Am Heart J 165, no. 2 (February 2013): 193–99. https://doi.org/10.1016/j.ahj.2012.10.029.
    Full Text Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Susanna Stevens, Kirkwood F. Adams, David J. Whellan, Mark P. Donahue, Dalane W. Kitzman, et al. “Elevated Galectin-3 Levels and Prediction of Mode of Death in Heart Failure: Insights from the HF-ACTION Study.” Circulation 126, no. 21 (November 20, 2012).
    Link to Item
  - Xiong, Glen L., Mona Fiuzat, Maragatha Kuchibhatla, Ranga Krishnan, Christopher M. O’Connor, Wei Jiang, and Wei SADHART-CHF Investigators. “Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.” Circ Heart Fail 5, no. 6 (November 2012): 688–92. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967620.
    Full Text Link to Item
  - Mentz, Robert J., Juan-Carlos Kaski, Gheorghe-Andrei Dan, Sidney Goldstein, Norman Stockbridge, Angeles Alonso-Garcia, Luis M. Ruilope, et al. “Implications of geographical variation on clinical outcomes of cardiovascular trials.” Am Heart J 164, no. 3 (September 2012): 303–12. https://doi.org/10.1016/j.ahj.2012.06.006.
    Full Text Link to Item
  - Fiuzat, Mona, Daniel Wojdyla, Dalane Kitzman, Jerome Fleg, Steven J. Keteyian, William E. Kraus, Ileana L. Piña, David Whellan, and Christopher M. O’Connor. “Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.” J Am Coll Cardiol 60, no. 3 (July 17, 2012): 208–15. https://doi.org/10.1016/j.jacc.2012.03.023.
    Full Text Link to Item
  - Farzaneh-Far, Afshin, Harry R. Phillips, Linda K. Shaw, Aijing Z. Starr, Mona Fiuzat, Christopher M. O’Connor, Ashwani Sastry, Leslee J. Shaw, and Salvador Borges-Neto. “Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.” Jacc Cardiovasc Imaging 5, no. 7 (July 2012): 715–24. https://doi.org/10.1016/j.jcmg.2012.01.019.
    Full Text Link to Item
  - O’Connor, Christopher M., Robert J. Mentz, Gad Cotter, Marco Metra, John G. Cleland, Beth A. Davison, Michael M. Givertz, et al. “The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.” Eur J Heart Fail 14, no. 6 (June 2012): 605–12. https://doi.org/10.1093/eurjhf/hfs029.
    Full Text Link to Item
  - Mentz, Robert J., Mona Fiuzat, Linda K. Shaw, Harry R. Phillips, Salvador Borges-Neto, G Michael Felker, and Christopher M. O’Connor. “Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease).” Am J Cardiol 109, no. 9 (May 1, 2012): 1272–77. https://doi.org/10.1016/j.amjcard.2011.12.021.
    Full Text Link to Item
  - Mentz, Robert J., Mona Fiuzat, Monica Kraft, Joann Lindenfeld, and Christopher M. O’Connor. “Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?” J Card Fail 18, no. 5 (May 2012): 413–22. https://doi.org/10.1016/j.cardfail.2012.02.002.
    Full Text Link to Item
  - Mentz, Robert J., Mona Fiuzat, Daniel M. Wojdyla, Karen Chiswell, Mihai Gheorghiade, Gregg C. Fonarow, and Christopher M. O’Connor. “Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.” Eur J Heart Fail 14, no. 4 (April 2012): 395–403. https://doi.org/10.1093/eurjhf/hfs009.
    Full Text Link to Item
  - Ahmad, Tariq, Mona Fiuzat, G Michael Felker, and Christopher O’Connor. “Novel biomarkers in chronic heart failure.” Nat Rev Cardiol 9, no. 6 (March 27, 2012): 347–59. https://doi.org/10.1038/nrcardio.2012.37.
    Full Text Link to Item
  - Jiang, Wei, Harry Oken, Mona Fiuzat, Linda K. Shaw, Carolyn Martsberger, Maragatha Kuchibhatla, Rima Kaddurah-Daouk, et al. “Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.” J Cardiovasc Transl Res 5, no. 1 (February 2012): 92–99. https://doi.org/10.1007/s12265-011-9325-8.
    Full Text Link to Item
  - Bettari, Luca, Mona Fiuzat, Linda K. Shaw, Daniel M. Wojdyla, Marco Metra, G Michael Felker, and Christopher M. O’Connor. “Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases.” J Card Fail 18, no. 1 (January 2012): 74–81. https://doi.org/10.1016/j.cardfail.2011.09.005.
    Full Text Link to Item
  - Dev, Sandesh, Robert M. Clare, G Michael Felker, Mona Fiuzat, Lynne Warner Stevenson, and Christopher M. O’Connor. “Link between decisions regarding resuscitation and preferences for quality over length of life with heart failure.” Eur J Heart Fail 14, no. 1 (January 2012): 45–53. https://doi.org/10.1093/eurjhf/hfr142.
    Full Text Link to Item
  - Felker, G Michael, Mona Fiuzat, Linda K. Shaw, Robert Clare, David J. Whellan, Luca Bettari, Shailesh C. Shirolkar, et al. “Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.” Circ Heart Fail 5, no. 1 (January 2012): 72–78. https://doi.org/10.1161/CIRCHEARTFAILURE.111.963637.
    Full Text Link to Item
  - O’Connor, Christopher M., Mona Fiuzat, Peter E. Carson, Inder S. Anand, Jonathan F. Plehn, Stephen S. Gottlieb, Marc A. Silver, et al. “Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.” Plos One 7, no. 10 (2012): e44324. https://doi.org/10.1371/journal.pone.0044324.
    Full Text Link to Item
  - Bettari, Luca, Mona Fiuzat, Gary M. Felker, and Christopher M. O’Connor. “Significance of hyponatremia in heart failure.” Heart Fail Rev 17, no. 1 (January 2012): 17–26. https://doi.org/10.1007/s10741-010-9193-3.
    Full Text Link to Item
  - O’Connor, Christopher M., David J. Whellan, Daniel Wojdyla, Eric Leifer, Robert M. Clare, Stephen J. Ellis, Lawrence J. Fine, et al. “Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.” Circ Heart Fail 5, no. 1 (January 2012): 63–71. https://doi.org/10.1161/CIRCHEARTFAILURE.111.963462.
    Full Text Link to Item
  - O’Connor, Christopher M., Mona Fiuzat, Joann Lindenfeld, Alan Miller, Carlo Lombardi, Peter Carson, Linda K. Shaw, et al. “Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes.” Am J Cardiol 108, no. 10 (November 15, 2011): 1449–57. https://doi.org/10.1016/j.amjcard.2011.06.065.
    Full Text Link to Item
  - O’Connor, Christopher M., Mona Fiuzat, Carlo Lombardi, Kenji Fujita, Gang Jia, Beth A. Davison, John Cleland, et al. “Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.” Circ Heart Fail 4, no. 6 (November 2011): 724–32. https://doi.org/10.1161/CIRCHEARTFAILURE.111.961581.
    Full Text Link to Item
  - O’Connor, Christopher M., and Mona Fiuzat. “Clinical trials in acute decompensated heart failure--over 50 years of research.” Heart Fail Clin 7, no. 4 (October 2011): xv–xvii. https://doi.org/10.1016/j.hfc.2011.06.015.
    Full Text Link to Item
  - Fiuzat, Mona, and Michael R. Bristow. “Pharmacogenetics in heart failure trials.” Heart Fail Clin 7, no. 4 (October 2011): 553–59. https://doi.org/10.1016/j.hfc.2011.06.010.
    Full Text Link to Item
  - Fiuzat, Mona, and Robert M. Califf. “Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trials.” Heart Fail Clin 7, no. 4 (October 2011): 539–44. https://doi.org/10.1016/j.hfc.2011.06.004.
    Full Text Link to Item
  - O’Connor, Christopher M., and Mona Fiuzat. “Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.” Heart Fail Clin 7, no. 4 (October 2011): 451–56. https://doi.org/10.1016/j.hfc.2011.06.013.
    Full Text Link to Item
  - O’Connor, Christopher M., Mona Fiuzat, Karl Swedberg, Michael Caron, Bruce Koch, Peter E. Carson, Wendy Gattis-Stough, Gordon W. Davis, and Michael R. Bristow. “Influence of global region on outcomes in heart failure β-blocker trials.” J Am Coll Cardiol 58, no. 9 (August 23, 2011): 915–22. https://doi.org/10.1016/j.jacc.2011.03.057.
    Full Text Link to Item
  - Bettari, L., M. Fiuzat, D. Wojdyla, L. Shaw, M. Metra, G. M. Felker, and C. O’Connor. “The independent prognostic value of hyponatremia in a cohort of heart failure patients: analysis from the Duke databank for cardiovascular disease.” European Heart Journal 32 (August 1, 2011): 134–134.
    Link to Item
  - Borges-Neto, Salvador, Linda K. Shaw, Mona Fiuzat, Robert Pagnanelli, and Christopher M. O’Connor. “Regadenoson Stress SPECT MPI for Prediction of Outcomes in Patients with Impaired Left Ventricular Function: A Comparison with Adenosine Stress.” Journal of Cardiac Failure 17, no. 8 (August 2011): S78–79. https://doi.org/10.1016/j.cardfail.2011.06.264.
    Full Text
  - Shah, Monica R., Robert M. Califf, Anju Nohria, Manju Bhapkar, Margaret Bowers, Donna M. Mancini, Mona Fiuzat, Lynne W. Stevenson, and Christopher M. O’Connor. “The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure.” J Card Fail 17, no. 8 (August 2011): 613–21. https://doi.org/10.1016/j.cardfail.2011.04.012.
    Full Text Link to Item
  - Bettari, Luca, Mona Fiuzat, Richard Becker, G Michael Felker, Marco Metra, and Christopher M. O’Connor. “Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions.” Circ Heart Fail 4, no. 3 (May 2011): 361–68. https://doi.org/10.1161/CIRCHEARTFAILURE.110.959957.
    Full Text Link to Item
  - Fiuzat, M., and C. M. O’Connor. “Bucindolol: new hopes from reviewing past data.” Drugs Today (Barc) 47, no. 5 (May 2011): 347–51. https://doi.org/10.1358/dot.2011.47.5.1579112.
    Full Text Link to Item
  - Gheorghiade, Mihai, Peter S. Pang, Christopher M. O’Connor, Krishna Prasad, John McMurray, John R. Teerlink, Mona Fiuzat, Hani Sabbah, and Michel Komajda. “Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase.” Am Heart J 161, no. 2 (February 2011): 224–32. https://doi.org/10.1016/j.ahj.2010.10.023.
    Full Text Link to Item
  - Fiuzat, Mona, Linda K. Shaw, Laine Thomas, G Michael Felker, and Christopher M. O’Connor. “United States stock market performance and acute myocardial infarction rates in 2008-2009 (from the Duke Databank for Cardiovascular Disease).” Am J Cardiol 106, no. 11 (December 1, 2010): 1545–49. https://doi.org/10.1016/j.amjcard.2010.07.027.
    Full Text Link to Item
  - Carson, Peter, Mona Fiuzat, Christopher O’Connor, Inder Anand, Jonathan Plehn, Jo Ann Lindenfeld, Marc Silver, et al. “Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]).” Am Heart J 160, no. 4 (October 2010): 649–54. https://doi.org/10.1016/j.ahj.2010.07.004.
    Full Text Link to Item
  - Shirolkar, Shailesh C., Mona Fiuzat, and Richard C. Becker. “Dronedarone and vitamin K antagonists: a review of drug-drug interactions.” Am Heart J 160, no. 4 (October 2010): 577–82. https://doi.org/10.1016/j.ahj.2010.07.008.
    Full Text Link to Item
  - O’Connor, Christopher M., and Mona Fiuzat. “Is rehospitalization after heart failure admission a marker of poor quality? Time for re-evaluation.” J Am Coll Cardiol 56, no. 5 (July 27, 2010): 369–71. https://doi.org/10.1016/j.jacc.2010.02.054.
    Full Text Link to Item
  - O’Connor, Christopher M., Vic Hasselblad, Rajendra H. Mehta, Gudaye Tasissa, Robert M. Califf, Mona Fiuzat, Joseph G. Rogers, Carl V. Leier, and Lynne W. Stevenson. “Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.” J Am Coll Cardiol 55, no. 9 (March 2, 2010): 872–78. https://doi.org/10.1016/j.jacc.2009.08.083.
    Full Text Link to Item
  - Murphy, Guinevere A., Mona Fiuzat, and Michael R. Bristow. “Targeting heart failure therapeutics: a historical perspective.” Heart Fail Clin 6, no. 1 (January 2010): 11–23. https://doi.org/10.1016/j.hfc.2009.08.008.
    Full Text Link to Item
  - O’Connor, Christopher, and Mona Fiuzat. “Antidepressant Use, Depression, and Poor Cardiovascular Outcomes: The Chicken or the Egg?: Comment on "Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study".” Arch Intern Med 169, no. 22 (December 14, 2009): 2140–41. https://doi.org/10.1001/archinternmed.2009.437.
    Full Text Link to Item
  - Fiuzat, Mona, Wei Jiang, John Spertus, Maragatha Kuchibhatla, Michael Cuffe, Ranga Krishnan, and Christopher O’Connor. “Effects of Successful Depression Intervention on Health Status in Patients with Chronic Heart Failure and Major Depressive Disorder: Findings from the SADHART-CHF Randomized Controlled Trial.” Journal of Cardiac Failure 15, no. 6 (August 2009): S86–S86. https://doi.org/10.1016/j.cardfail.2009.06.069.
    Full Text
  - O’Connor, Erin, Wei Jiang, Maragatha Kuchibhatla, Greg Clary, Michael Cuffe, Eric Christopher, Jude Alexander, Mona Fiuzat, Christopher O’Connor, and Ranga Krishnan. “Marital Status and Prognosis of Patients with Heart Failure.” Journal of Cardiac Failure 15, no. 6 (August 2009): S91–S91. https://doi.org/10.1016/j.cardfail.2009.06.085.
    Full Text
  - Fiuzat, Mona, G Michael Felker, Mark P. Donahue, and Christopher M. O’Connor. “Using genetic information to select treatment for patients with heart failure: has the time come?” Per Med 6, no. 4 (July 2009): 385–92. https://doi.org/10.2217/pme.09.19.
    Full Text Link to Item
  - Perell, Karen L., Maria Lyn P. Manzano, Robert Weaver, Mona Fiuzat, Michelle Voss-McCarthy, Dorene Opava-Rutter, and Steven C. Castle. “Outcomes of a consult fall prevention screening clinic.” Am J Phys Med Rehabil 85, no. 11 (November 2006): 882–88. https://doi.org/10.1097/01.phm.0000233209.49518.46.
    Full Text Link to Item
  - Hixson-Wallace, J. A., and M. Fiuzat. “Histamine-2 (H2) receptor antagonists may not necessarily cross-react to induce thrombocytopenia.” Journal of Pharmacy Practice 11, no. 1 (January 1, 1998): 2–3. https://doi.org/10.1177/089719009801100101.
    Full Text
- Conference Papers
  - Johansen, Niklas Dyrby, Muthiah Vaduganathan, Deewa Zahir, Mona Fiuzat, Ersilia M. DeFilippis, James L. Januzzi, Javed Butler, et al. “A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study.” In Circ Heart Fail, 16:e009729, 2023. https://doi.org/10.1161/CIRCHEARTFAILURE.122.009729.
    Full Text Link to Item
  - Fiuzat, Mona, Marco Sbolli, Dario S. Cani, Christopher O’Connor, William Abraham, Mitchell Psotka, and James Januzzi. “Guideline Directed Medical Therapy in Heart Failure Trials: A New Proposed Scoring System.” In Journal of Cardiac Failure, 25:S77–S77. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.219.
    Full Text
  - Fiuzat, Mona, Wendimagegn Alemayehu, Justin Ezekowitz, Cindy Westerhout, David Whellan, Hillary Mulder, Tariq Ahmad, et al. “Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial.” In Journal of Cardiac Failure, 25:S78–S78. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.221.
    Full Text
  - McIlvennan, Colleen K., Mitchell A. Psotka, Mona Fiuzat, Palak Shah, Susan E. Ammon, Biykem Bozkurt, Eugene S. Chung, et al. “Differences between Academic and Non-Academic Institutions in Heart Failure Clinical Trials in North America: Insights from the HFSA Research Network Survey.” In Journal of Cardiac Failure, 25:S76–77. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.217.
    Full Text
  - Sinha, Shashank S., Mitchell A. Psotka, Mona Fiuzat, Scott D. Barnett, Norman Stockbridge, Ellis F. Unger, Mary DeSouza, et al. “Barriers to Clinical Trial Efficiency: The Heart Failure Collaboratory Industry Experience.” In Journal of Cardiac Failure, 25:S80–S80. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.226.
    Full Text
  - Wan, Luxi, Christopher O’Connor, Amanda Stebbins, Brooke Alhanti, Marc D. Samsky, Haider J. Warraich, Kimberly S. Johnson, et al. “Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF.” In Journal of Cardiac Failure, 25:S154–55. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.444.
    Full Text
  - Greene, Stephen J., Christopher M. O’Connor, Jie-Lena Sun, Mona Fiuzat, William E. Kraus, Brooke Alhanti, Ileana L. Pina, David Whellan, and Robert J. Mentz. “Clinical Outcomes Associated With Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction: From the HF-ACTION Trial.” In Circulation, Vol. 140, 2019.
    Link to Item
  - Ho, Annie H., Ayman Samman Tahhan, Muthiah Vaduganathan, Stephen J. Greene, Alaaeddin Alrohaibani, Gregg C. Fonarow, Javed Butler, et al. “Representation of Women Authors in Contemporary Heart Failure Clinical Trials.” In Circulation, Vol. 140, 2019.
    Link to Item
  - Mentz, Robert J., Christopher M. O’Connor, Bradi B. Granger, Hongqiu Yang, Chetan B. Patel, Karen E. Steinhauser, Mona Fiuzat, et al. “Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial.” In Am Heart J, 204:202–4, 2018. https://doi.org/10.1016/j.ahj.2018.07.010.
    Full Text Link to Item
  - Ammon, Susan, Biykem Bozkurt, Eugene Chung, Robert Cole, Patrice Desvigne-Nickens, Mona Fiuzat, Stephen Greene, et al. “Heart Failure Society of America Research Network Survey.” In Journal of Cardiac Failure, 24:S9–S9. Elsevier BV, 2018. https://doi.org/10.1016/j.cardfail.2018.07.031.
    Full Text
  - Tahhan, Ayman Samman, Muthiah Vaduganathan, Stephen Greene, Gregg Fonarow, Mona Fiuzat, Mariell Jessup, JoAnn Lindenfeld, Christopher O’Connor, and Javed Butler. “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials.” In Journal of Cardiac Failure, 24:S58–59. Elsevier BV, 2018. https://doi.org/10.1016/j.cardfail.2018.07.262.
    Full Text
  - Fudim, M Marat, S. J. Doerfler, A. Coles, S. J. Greene, L. B. Cooper, M. Fiuzat, C. M. O’connor, J. G. Rogers, and R. J. Mentz. “Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the escape trial.” In European Journal of Heart Failure, 20:548–548. WILEY, 2018.
    Link to Item
  - Lindenfeld, JoAnn, Olaf Oldenburg, David Whellan, Mona Fiuzat, Naresh Punjabi, Dalane Kitzman, Amy Blase, and Adam Benjafield. “GLOBAL RANK ENDPOINT USING NT-PROBNP VERSUS 6 MINUTE WALK DISTANCE IN HF PATIENTS: ANALYSIS FROM THE CAT-HF TRIAL.” In Journal of the American College of Cardiology, 71:A795–A795. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)31336-6.
    Full Text
  - O’Connor, Christopher M., Mona Fiuzat, Adrian Coles, Hillary Mulder, Kevin Anstrom, Tariq Ahmad, Kirkwood Adams, et al. “CO-MORBIDITIES AND ETHNICITY/RACE PREDICT MORBIDITY AND MORTALITY IN HIGH RISK HEART FAILURE PATIENTS WITH SYSTOLIC DYSFUNCTION: THE GUIDE-IT PREDICTIVE RISK MODEL.” In Journal of the American College of Cardiology, 71:A840–A840. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)31381-0.
    Full Text
  - Pristera, Nicole, Eric Yow, Pamela S. Douglas, Huiman X. Barnhart, Eric Leifer, Lawton Cooper, Patrice Desvigne-Nickens, et al. “Predictors and Outcomes of Reverse Remodeling in Heart Failure With Reduced Ejection Fraction.” In Circulation, Vol. 138, 2018.
    Link to Item
  - Granger, Bradi B., Hongqiu Yang, Robert J. Mentz, Daniel B. Mark, Donald H. Taylor, Karen E. Steinhauser, Gwen C. Dodson, et al. “The Impact of a Palliative Care Intervention on Polypharmacy in Advanced HF: Results From Pal-HF.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
    Link to Item
  - Daubert, Melissa A., Eric Yow, Huiman Barnhart, Pamela S. Douglas, Susan Rimmer, Casey Norris, Lawton Copper, et al. “Biomarker-Guided Heart Failure Therapy Results in Significant Reverse Left Ventricular Remodeling Among Patients Achieving NT-proBNP Goal: Insights From the GUIDE-IT Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
    Link to Item
  - Felker, G Michael, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L. Januzzi, et al. “Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” In Journal of Cardiac Failure, 23:830–830. Elsevier BV, 2017. https://doi.org/10.1016/j.cardfail.2017.10.004.
    Full Text
  - Benjafield, Adam, JoAnn Lindenfeld, Olaf Oldenburg, David Whellan, Mona Fiuzat, Naresh Punjabi, Kevin Anstrom, Amy Blase, and Holger Woehrle. “SURROGATE ENDPOINTS AND THE DIFFERENTIAL RESPONSE TO ASV FOR SLEEP APNEA IN HFREF VERSUS HFPEF IN THE CAT-HF TRIAL.” In Journal of the American College of Cardiology, 69:708–708. Elsevier BV, 2017. https://doi.org/10.1016/s0735-1097(17)34097-4.
    Full Text
  - Sharma, Abhinav, Susanna R. Stevens, Adrian Coles, Mona Fiuzat, Kirkwood F. Adams, David J. Whellan, Mark P. Donahue, et al. “A Multi-Marker Approach for Risk Stratification in Patients With Chronic Heart Failure: Insights From the HF-ACTION Trial,” 136:A17332–A17332. American Heart Association, Inc., 2017.
  - Daubert, Melissa, Olaf Oldenberg, David Whellan, Gudaye Tasissa, Holger Woehrle, Naresh Punjabi, Kevin Anstrom, et al. “Treatment of Sleep-Disordered Breathing and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction: Insights From the CAT-HF Trial.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
    Link to Item
  - Oldenburg, Olaf, David Whellan, JoAnn Lindenfeld, Mona Fiuzat, Naresh Punjabi, Adam Benjafield, Amy Blase, Holger Woehrle, and Christopher O’Connor. “Prevalence of Sleep Disordered Breathing and Mortality Follow-Up in an Acute Decompensated Heart Failure Population.” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
    Link to Item
  - Mentz, Robert J., G Michael Felker, Robert Cole, Kirkwood F. Adams, Gregory Egnaczyk, Mona Fiuzat, Chetan B. Patel, et al. “The Targeting Acute Congestion with Tolvaptan in Congestive Heart Failure Study: A Randomized, Double blind, Placebo-Controlled Trial in Acute Heart Failure.” In Journal of Cardiac Failure, 22:939–939. Elsevier BV, 2016. https://doi.org/10.1016/j.cardfail.2016.09.010.
    Full Text
  - Punjabi, Naresh, Olaf Oldenburg, David Whellan, Mona Fiuzat, JoAnn Lindenfeld, Adam Benjafield, Amy Blase, Holger Woehrle, and Christopher O’Connor. “Prevalence of Sleep Disordered Breathing in an Acute Decompensated Heart Failure Population.” In Chest, 150:1263A-1263A. Elsevier BV, 2016. https://doi.org/10.1016/j.chest.2016.08.1377.
    Full Text
  - Sharma, A., S. Stevens, J. Lucas, M. Fiuzat, K. F. Adams, D. J. Whellan, M. P. Donahue, et al. “Prognostic Utility of GDF-15 in Chronic Heart Failure: Insights From the HF-ACTION Study.” In European Heart Journal, 37:441–441. OXFORD UNIV PRESS, 2016.
    Link to Item
  - Luo, Nancy, Peter Merrill, David J. Whellan, Ileana L. Pina, Mona Fiuzat, William E. Kraus, Dalane W. Kitzman, Steven J. Keteyian, Christopher M. O’Connor, and Robert J. Mentz. “Exercise Training in Patients with Chronic Heart Failure and Atrial Fibrillation: Results from the HF-ACTION Trial.” In Journal of Cardiac Failure, 22:S71–S71. Elsevier BV, 2016. https://doi.org/10.1016/j.cardfail.2016.06.225.
    Full Text
  - O’connor, C., D. Whellan, M. Fiuzat, A. Benjafield, H. Woehrle, N. Punjabi, K. Anstrom, A Amy Blase, J. Lindenfeld, and O. Oldenburg. “Adaptive servo-ventilation in heart failure: results of a randomized, controlled clinical trial.” In European Journal of Heart Failure, 18:318–318. WILEY-BLACKWELL, 2016.
    Link to Item
  - Punjabi, N., D. Whellan, M. Fiuzat, A. Benjafield, H. Woehrle, K. J. Anstrom, A. Blase, J. Lindenfeld, O. Oldenburg, and C. O’Connor. “Cardiovascular Improvements With Adaptive Servo-Ventilation In Heart Failure: Insights From The Cat-Hf Trial.” In American Journal of Respiratory and Critical Care Medicine, Vol. 193. AMER THORACIC SOC, 2016.
    Link to Item
  - Mentz, Robert J., Kishan Parikh, Adrian Coles, Phillip J. Schulte, William E. Kraus, Jerome L. Fleg, Steven J. Keteyian, et al. “Implications of Angina Pectoris on Quality of Life, Functional Capacity and Clinical Outcomes in Chronic Heart Failure Patients: Insights From HF-ACTION.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.
    Link to Item
  - Banks, Adam Z., Robert Mentz, Amanda Stebbins, Catherine Mikus, Phillip Schulte, Jerome Fleg, Lawton Cooper, et al. “RESPONSE TO EXERCISE TRAINING AND OUTCOMES IN HEART FAILURE PATIENTS WITH DIABETES MELLITUS: INSIGHTS FROM HF-ACTION.” In Journal of the American College of Cardiology, 65:A1034–A1034. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)61034-8.
    Full Text
  - Gandhi, Parul U., Shweta Motiwala, Arianna Belcher, Hanna Gaggin, Rory Weiner, Aaron Baggish, Mona Fiuzat, Hans-Peter Brunner-La Rocca, and James Januzzi. “ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION.” In Journal of the American College of Cardiology, 65:A970–A970. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60970-6.
    Full Text
  - Kelly, Jacob P., Robert Mentz, Phillip Schulte, Allison Dunning, Mona Fiuzat, Steven Keteyian, Jerome Fleg, et al. “STATINS AND EXERCISE TRAINING RESPONSE IN HEART FAILURE PATIENTS: INSIGHTS FROM THE HF-ACTION TRIAL.” In Journal of the American College of Cardiology, 65:A874–A874. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60874-9.
    Full Text
  - Parikh, Kishan S., Mona Fiuzat, Megan Neely, Tariq Ahmad, G Michael Felker, Ileana Pina, Kirkwood Adams, et al. “ADRENERGIC RECEPTOR POLYMORPHISMS INTERACT WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES ESPECIALLY IN BLACK RACE: RESULTS FROM HF-ACTION DNA SUBSTUDY.” In Journal of the American College of Cardiology, 65:A794–A794. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60794-x.
    Full Text
  - Parikh, Kishan S., Mona Fiuzat, Megan Neely, Tariq Ahmad, G Michael Felker, Ileana Pina, Kirkwood Adams, et al. “ALPHA-2C ADRENERGIC RECEPTOR POLYMORPHISM INTERACTS WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES DIFFERENTLY IN BLACK RACE: RESULTS FROM THE HF-ACTION DNA SUBSTUDY.” In Journal of the American College of Cardiology, 65:A964–A964. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60964-0.
    Full Text
  - Mentz, Robert J., Jonathan Buggey, Phillip J. Schulte, Adam D. DeVore, Kevin J. Anstrom, Eric L. Eisenstein, Mona Fiuzat, Christopher M. O’Connor, and Eric J. Velazquez. “Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital.” In Journal of Cardiac Failure, 20:S95–S95. Elsevier BV, 2014. https://doi.org/10.1016/j.cardfail.2014.06.267.
    Full Text
  - Valente, Mattia A. E., Adriaan A. Voors, Kevin Damman, Dirk J. Van Veldhuisen, Barrie M. Massie, Christopher M. O’Connor, Marco Metra, et al. “Diuretic response in acute heart failure: clinical characteristics and prognostic significance.” In Eur Heart J, 35:1284–93, 2014. https://doi.org/10.1093/eurheartj/ehu065.
    Full Text Link to Item
  - Mentz, Robert J., Phillip Schulte, Vera Bittner, Jerome Fleg, Steven Keteyian, William Kraus, Ileana Pina, et al. “SOCIOECONOMIC STATUS, MARITAL STATUS AND OUTCOMES IN HEART FAILURE: FINDINGS FROM HF-ACTION.” In Journal of the American College of Cardiology, 63:A733–A733. Elsevier BV, 2014. https://doi.org/10.1016/s0735-1097(14)60733-6.
    Full Text
  - Garber, Adam M., Robert J. Mentz, Linda K. Shaw, Hussein R. Al-Khalidi, Mona Fiuzat, Christopher O’Connors, and Eric J. Velazquez. “Predictors of Left Ventricular Thrombus Following ST-Segment Elevation Myocardial Infarction: Findings From the Duke Databank of Cardiovascular Disease and the Duke Echocardiography Databank.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.
    Link to Item
  - Mentz, Robert J., Gad Cotter, John G. Cleland, Susanna R. Stevens, Beth A. Davison, John R. Teerlinks, Marco Metra, et al. “Regional Differences in Heart Failure Medication Changes During Acute Heart Failure Hospitalization: Findings From the PROTECT Trial.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.
    Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Susanna Stevens, Phillip Schulte, William E. Kraus, David Whellan, Dalane Kitzman, et al. “Incremental Prognostic Utility by Cost and Complexity in Chronic Heart Failure.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.
    Link to Item
  - Mentz, Robert J., Samuel Broderick, Linda K. Shaw, Karen Chiswell, Mona Fiuzat, and Christopher M. O’Connor. “Clinical Characteristics and Outcomes of Patients With Ischemic Cardiomyopathy and Persistent Angina Pectoris: From the Duke Databank for Cardiovascular Disease.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.
    Link to Item
  - Borges-Neto, S., P. L. Hess, L. K. Shaw, R. Claire, R. Pagnanelli, M. Fiuzat, S. M. Al-Khatib, J. Piccini, and C. M. O’Connor. “Mechanical dyssynchrony defined by phase analysis from GSPECT: Does it predict all cause and cardiovascular mortality?” In European Heart Journal, 34:341–341. OXFORD UNIV PRESS, 2013.
    Link to Item
  - Ahmad, Tariq, Mona Fiuzat, Ben Neely, Megan Neely, Kirkwood Adams, David Whellan, Mark Donahue, et al. “RELATIONSHIP BETWEEN EXERCISE TRAINING AND CHANGES IN BIOMARKERS OF MYOCARDIAL STRESS, INJURY AND INFLAMMATION IN PATIENTS WITH CHRONIC HEART FAILURE.” In Journal of the American College of Cardiology, 61:E759–E759. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)60759-7.
    Full Text
  - Mentz, Robert J., Samuel Broderick, Linda Shaw, Mona Fiuzat, and Christopher O’Connor. “ASSOCIATION BETWEEN ANGINA AND OUTCOMES IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: ANALYSIS FROM THE DUKE DATABANK FOR CARDIOVASCULAR DISEASE.” In Journal of the American College of Cardiology, 61:E682–E682. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)60682-8.
    Full Text
  - Borges-Neto, S., R. M. Mintz, L. K. S. Shaw, Z. S. Starr, M. F. Fiuzat, and C. M. O. O’Connor. “Ischemia change in heart failure patients with stable coronary artery disease is an independent predictor of death and myocardial infarction.” In European Heart Journal, 33:1020–1020. OXFORD UNIV PRESS, 2012.
    Link to Item
  - Mentz, R. J., P. J. Schulte, D. W. Kitzman, M. Fiuzat, W. E. Kraus, I. L. Pina, S. J. Keteyian, et al. “Beta-Blocker Selectivity in Heart Failure (HF) Patients With Chronic Obstructive Pulmonary Disease (COPD): Insights from HF-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION).” In Journal of Cardiac Failure, 18:S63–S63. Elsevier BV, 2012. https://doi.org/10.1016/j.cardfail.2012.06.216.
    Full Text
  - Metra, M., K. Chiswell, M. Fiuzat, V. Lazzarini, J. Horton, B. Davison, J. Cleland, et al. “Age, Clinical Characteristics and Outcomes of Patients With Acute Decompensated Heart Failure: Insights from the PROTECT Trial.” In Journal of Cardiac Failure, 18:S76–S76. Elsevier BV, 2012. https://doi.org/10.1016/j.cardfail.2012.06.484.
    Full Text
  - Ahmad, Tariq, G Michael Felker, Mona Fiuzat, Vivian Thompson, Linda Shaw, Kirkwood Adams, David Whellan, et al. “INTERACTION BETWEEN ST2 LEVELS AND EXERCISE TRAINING IN PATIENTS WITH CHRONIC HEART FAILURE: ANALYSIS FROM THE HF-ACTION TRIAL.” In Journal of the American College of Cardiology, 59:E940–E940. Elsevier BV, 2012. https://doi.org/10.1016/s0735-1097(12)60941-3.
    Full Text
  - Cleland, John, Karen Chiswell, Gerasimos Filippatos, Michael Givertz, Barry Massie, Gad Cotter, Beth Davison, et al. “QUALITY OF LIFE 60 DAYS AFTER AN ACUTE HEART FAILURE EVENT: INSIGHTS FROM THE PROTECT TRIAL.” In Journal of the American College of Cardiology, 59:E1032–E1032. Elsevier BV, 2012. https://doi.org/10.1016/s0735-1097(12)61033-x.
    Full Text
  - Mentz, Robert J., Daniel Wojdyla, Mona Fiuzat, Karen Chiswell, Tariq Ahmad, Gregg Fonarow, and Christopher O'Connor. “THE ASSOCIATION OF BETA-BLOCKER USE AND SELECTIVITY WITH OUTCOMES IN HEART FAILURE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FINDINGS FROM THE ORGANIZED PROGRAM TO INITIATE LIFE-SAVING TREATMENT IN HOSPITALIZED PATIENTS WITH HEART FAILURE.” In Journal of the American College of Cardiology, 59:E862–E862. Elsevier BV, 2012. https://doi.org/10.1016/s0735-1097(12)60863-8.
    Full Text
  - Fiuzat, Mona, Daniel Wojdyla, David Whellan, Karen Chiswell, Dalane Kitzman, William Kraus, Steven Keteyian, et al. “Relationship of Beta-Blocker (BB) Dose with Outcomes in Ambulatory Heart Failure (HF) Patients with Systolic Dysfunction: Results from the HF-ACTION Trial.” In Circulation, Vol. 124. LIPPINCOTT WILLIAMS & WILKINS, 2011.
    Link to Item
  - Fiuzat, M., B. Massie, K. Chiswell, M. Givertz, B. Davison, G. Cotter, J. Cleland, et al. “International Differences in Acute Heart Failure (AHF) Patients: Insight from the PROTECT Trial.” In Journal of Cardiac Failure, 17:S59–60. Elsevier BV, 2011. https://doi.org/10.1016/j.cardfail.2011.06.203.
    Full Text
  - Mentz, R. J., M. Fiuzat, D. Wojdyla, K. Chiswell, K. Pieper, M. Gheorghiade, G. C. Fonarow, and C. M. O’Connor. “Clinical Characteristics and Outcomes for Hospitalized Heart Failure (HF) Patients with Chronic Obstructive Pulmonary Disease (COPD): Findings from OPTIMIZE-HF.” In Journal of Cardiac Failure, 17:S86–87. Elsevier BV, 2011. https://doi.org/10.1016/j.cardfail.2011.06.293.
    Full Text
  - Mentz, R. J., M. Fiuzat, K. Chiswell, D. Wojdyla, B. Davison, J. Cleland, H. C. Dittrich, et al. “The PROTECT In-Hospital Risk Model: 7-Day Outcome in Patients Hospitalized with Acute Heart Failure (AHF) and Renal Dysfunction.” In Journal of Cardiac Failure, 17:S77–S77. Elsevier BV, 2011. https://doi.org/10.1016/j.cardfail.2011.06.258.
    Full Text
  - Mentz, R. J., M. Fiuzat, L. Shaw, S. Borges-Neto, H. R. Phillips, M. Gheorghiade, and C. M. O’Connor. “Clinical Characteristics and Outcomes of Patients with Ischemic Cardiomyopathy (ICM) and Angina: Findings from the Duke Cardiovascular Database.” In Journal of Cardiac Failure, 17:S81–82. Elsevier BV, 2011. https://doi.org/10.1016/j.cardfail.2011.06.276.
    Full Text
  - Borges-Neto, S., H. Phillips, A. Farzaneh-Far, Z. Starr, L. K. Shaw, M. Fiuzat, and C. O’connor. “SPECT MPI worsening ischemia and reclassification in CAD patients: a comparison of medical therapy versus revascularization.” In European Heart Journal Supplements, 13:A48–A48. OXFORD UNIV PRESS, 2011.
    Link to Item
  - Fiuzat, Mona, Luca Bettari, Linda K. Shaw, Shirolkar Shailesh, Michael G. Felker, and Christopher M. O’Connor. “HYPONATREMIA AND LONG-TERM OUTCOMES IN HEART FAILURE.” In Journal of the American College of Cardiology, 57:E1268–E1268. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61268-0.
    Full Text
  - Farzaneh-Far, Afshin, Harry R. Phillips, Linda K. Shaw, Mona Fiuzat, Christopher O’Connor, and Salvador Borges-Neto. “Greater Ischemia Reduction and Associated Improved Survival with Revascularization Compared to Medical Therapy in Patients with Stable Corollary Artery Disease.” In Journal of the American College of Cardiology, 56:B88–B88. ELSEVIER SCIENCE INC, 2010.
    Link to Item
  - Felker, G. M., M. Fiuzat, L. K. Shaw, M. Donahue, K. F. Adams, F. Zannad, D. Whellan, D. Kitzman, I. Pina, and C. M. O’connor. “Prognostic value of Galectin-3 in chronic heart failure: results from the HF-ACTION Study.” In European Heart Journal, 31:429–429. OXFORD UNIV PRESS, 2010.
    Link to Item
  - Allen, Larry, Mona Fiuzat, Gordon Davis, G Michael Felker, and Michael Bristow. “Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST).” In Journal of Cardiac Failure, 16:S65–S65. Elsevier BV, 2010. https://doi.org/10.1016/j.cardfail.2010.06.224.
    Full Text
  - Borges-Neto, Salvadore, Afshin Farzaneh-Far, Linda K. Shaw, Mona Fiuzat, Harry Phillips, Eric Velazquez, and Christopher M. O’Connor. “Revascularization Leads to Greater Reduction in Ischemia Than Medical Therapy in Patients With Left Ventricular Dysfunction and Stable Coronary Artery Disease.” In Journal of Cardiac Failure, 16:S113–S113. Elsevier BV, 2010. https://doi.org/10.1016/j.cardfail.2010.06.395.
    Full Text
  - Dev, Sandesh, Robert Clare, Mona Fiuzat, G Michael Felker, and Christopher M. O’Connor. “The Association of Do-Not-Resuscitate Preference With Quality of Life Preference and Mortality in Patients in the ESCAPE Trial.” In Journal of Cardiac Failure, 16:S103–S103. Elsevier BV, 2010. https://doi.org/10.1016/j.cardfail.2010.06.359.
    Full Text
  - O’Connor, Christopher, Mona Fiuzat, Joseph Rogers, Gudaye Tassisa, Victor Hasselblad, and G Michael Felker. “Endpoint Comparisons in an Advanced Heart Failure Trial: Data From the ESCAPE Trial.” In Circulation, 120:S881–S881. LIPPINCOTT WILLIAMS & WILKINS, 2009.
    Link to Item
  - Dev, Sandesh, Mona Fiuzat, Christopher O’Connor, Gudaye Tassisa, and Joseph Rogers. “Baseline Characteristics and Outcomes of Patients Who Do Not Desire Resuscitation: An Analysis of the ESCAPE Trial.” In Journal of Cardiac Failure, 15:S91–S91. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2009.
    Link to Item
  - Lindenfeld, JoAnn, Mona Fiuzat, Gordon Davis, and Michael Bristow. “Bucindolol Decreases Time to First HF Hospitalization in Patients with Chronic Kidney Disease.” In Journal of Cardiac Failure, 15:S74–75. Elsevier BV, 2009. https://doi.org/10.1016/j.cardfail.2009.06.170.
    Full Text
  - O’Connor, Christopher, Mona Fiuzat, Michael Caron, Bruce Koch, Gordon Davis, and Michael Bristow. “Influence of Varying Geographic Populations on Outcomes in Large Beta-Blocker Trials in Heart Failure.” In Journal of Cardiac Failure, 15:S75–76. Elsevier BV, 2009. https://doi.org/10.1016/j.cardfail.2009.06.174.
    Full Text
  - Rogers, Joseph, Mona Fiuzat, Gudaye Tassisa, and Christopher O’Connor. “Mode of Death in Advanced Heart Failure: Impact of Race, Etiology and Hemodynamics in the ESCAPE Trial.” In Journal of Cardiac Failure, 15:S86–S86. Elsevier BV, 2009. https://doi.org/10.1016/j.cardfail.2009.06.070.
    Full Text
  - Bristow, Michael, Eric Eichhorn, Hector Ventura, Bruce Koch, Mona Fiuzat, Gordon Davis, and A Douglas Robertson. “Beta-Blocker Evaluation of Survival Trial (BEST) Findings Show Benefit of Bucindolol in Moderate to Severe HF Patients, According to Prespecified Statistical Analysis Plan.” In Journal of the American College of Cardiology, 53:A157–A157. ELSEVIER SCIENCE INC, 2009.
    Link to Item
  - O’Connor, Christopher M., Bruce Koch, Mona Fiuzat, Gordon Davis, and Michael R. Bristow. “All-Cause Mortality Endpoint Comparison in Large Beta-Blocker Heart Failure Trials: United States (US) Versus Rest of World (ROW).” In Journal of the American College of Cardiology, 53:A154–A154. ELSEVIER SCIENCE INC, 2009.
    Link to Item
  - O’Connor, C., I. Anand, M. Fiuzat, J. Plehn, S. Goulieb, M. Silver, J. Lindenfeld, et al. “Additive effects of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotype combinations on adjudicated hospitalizations and death in the beta-blocker evaluation of survival trial (BEST).” In Journal of Cardiac Failure, 14:S69–S69. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2008.
    Link to Item
  - Carson, Peter, Stephen Gottleib, Inder Anand, Johnathan Plehn, Marc Silver, JoAnn Lindenfeld, O’Connor Chris, et al. “Determination of Hospitalization Type by Investigator Case Report Form or Adjudication Committee in a Large Heart Failure Clinical Trial (BEST).” In Journal of Cardiac Failure, 14:S93–S93. Elsevier BV, 2008. https://doi.org/10.1016/j.cardfail.2008.06.258.
    Full Text
  - Lindenfeld, JoAnn, Johnathan Plehn, Stephen B. Liggett, J David Port, Mona Fiuzat, A Douglas Robertson, Chakra Budhathoki, and Michael R. Bristow. “Different Patterns of LVEF/Remodeling and Clinical Endpoint Effects for Bucindolol in b 1 -AR 389 Arg/Gly Genotypes.” In Journal of Cardiac Failure, 14:S40–41. Elsevier BV, 2008. https://doi.org/10.1016/j.cardfail.2008.06.287.
    Full Text
  - Lindenfeld, JoAnn, Stephen B. Liggett, Johnathan Plehn, J David Port, Mona Fiuzat, Chakra Budhathoki, and Michael R. Bristow. “Ischemic Cardiomyopathy Response to Bucindolol May Be Differentially Influenced by b 1 389 Arg/Gly and a 2c Genotypes.” In Journal of Cardiac Failure, 14:S77–78. Elsevier BV, 2008. https://doi.org/10.1016/j.cardfail.2008.06.431.
    Full Text
  - Carson, Peter, Michel White, Inder Anand, Jonathan Plehn, Stephen Gottlieb, Marc Silver, Joann Lindenfeld, et al. “Effect of beta(1) 389 Arg/Gly alpha(2c) 322-325 Wt/Del genotypes on adjudicated hospitalizations in the BEST trial.” In Circulation, 116:649–649. LIPPINCOTT WILLIAMS & WILKINS, 2007.
    Link to Item
  - White, Michel, Peter Carson, Inder S. Anand, Stephen S. Gottlieb, JoAnn Lindenfeld, Christopher O’Connor, Alan Miller, et al. “Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 Arg/Gly receptor polymorphism.” In Circulation, 116:176–176. LIPPINCOTT WILLIAMS & WILKINS, 2007.
    Link to Item
  - White, M., M. R. Bristow, I. S. Anand, S. S. Gottlieb, J. Lindenfeld, C. O’Connor, A. Miller, et al. “Effects of bucindolol on cardiovascular mortality and morbidity are determined by the beta-1 389 ARG/GLY receptor polymorphism.” In Canadian Journal of Cardiology, 23:169C-169C. PULSUS GROUP INC, 2007.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

Selected Grants

Selected Publications

Academic Articles

Conference Papers